-

Anthem’s affiliated health plans waive member costs for COVID-19 testing, while supporting telehealth and 90-day maintenance medication supply

INDIANAPOLIS--(BUSINESS WIRE)--Amid the growing concerns about the spread of the COVID-19 in communities across the country, Anthem, Inc., announced today its efforts to eliminate the burden of additional costs for members in its affiliated health plans by providing coverage of the coronavirus screening test at no out-of-pocket-cost. The companies also confirm that prior authorization is not required for diagnostic services related to COVID-19 testing.

“We are committed to keeping healthcare affordable for the consumers we serve. While the CDC continues to advise that the risk for the virus remains low, we are mindful of our responsibility to our health plan consumers and communities to ensure access to care,” said Anthem President and CEO Gail K. Boudreaux. “These actions today should reduce barriers to seeing a doctor, getting tested and maintaining adherence to medications for long-term health issues.”

Testing similar to what is offered now from the Centers for Disease Control will soon be offered more broadly. Anthem’s waiver of copays, coinsurance and deductibles and prior authorization will extend to this focused test used to diagnose COVID-19 for all of Anthem’s affiliated health plan fully-insured, individual, Medicaid and Medicare members when medically necessary.

Anthem also recommends members use telehealth when possible, as it can help prevent them from spreading a virus further within a physical clinical setting. Anthem’s telehealth provider, LiveHealth Online, is a safe and effective way for members to see a doctor to receive health guidance related to COVID-19 from their homes via smart phone, tablet or computer-enabled web cam. LiveHealth Online is offered as a health plan benefit to many individual, employer-sponsored and Medicaid and Medicare members. It is also available as a cost effective option to all consumers.

As there is a heightened awareness of COVID-19 and more cases are diagnosed in the United States, LiveHealth Online is increasing physician availability to handle a potential increase in patients, while maintaining reasonable wait times.

Anthem is also encouraging its health plan members who have a pharmacy plan that includes a 90-day benefit, to talk to their doctor about whether changing from a 30-day supply to a 90-day supply of any prescription medicines they take on a regular basis is appropriate. Members filling 90-day prescriptions can obtain their medications through our home delivery pharmacy and, in some circumstances, select retail pharmacies. Preparing with a longer supply could help to avoid any potential issues with localized shortages. Members can call the pharmacy services number on the back of their health plan ID card to learn more.

About Anthem, Inc.

Anthem is a leading health benefits company dedicated to improving lives and communities, and making healthcare simpler. Through its affiliated companies, Anthem serves more than 79 million people, including 41 million within its family of health plans. We aim to be the most innovative, valuable and inclusive partner. For more information, please visit www.antheminc.com or follow @AnthemInc on Twitter.

Contacts

Jill Becher, 414-234-1573

Anthem, Inc.

NYSE:ANTM

Release Versions

Contacts

Jill Becher, 414-234-1573

More News From Anthem, Inc.

Elevance Health Names Jeff Park President of Carelon

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) today announced the appointment of Jeff Park as President of Carelon, effective December 1, 2026. In this role, Park will lead Carelon through its next phase of growth, building on its momentum and expanding its ability to improve affordability, enhance the consumer experience, and create greater value for customers and the people it serves. Park joins Carelon at a time of significant opportunity as demand continues to grow for integrat...

Elevance Health Reports Third Quarter 2026 Results; Raises Full-Year Guidance

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported third quarter 2026 results ahead of expectations. "Elevance Health's third quarter results reflect stronger execution across our diversified portfolio and underscore the earnings power of the business. We are raising our 2026 earnings outlook and remain confident in delivering at least 12% growth in adjusted diluted earnings per share in 2027 from our higher earnings baseline of at least $26.753. By bringing together the...

Elevance Health to Hold Conference Call and Webcast to Discuss Third Quarter 2026 Results on October 21, 2026

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release third quarter 2026 financial results on October 21, 2026 at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 - Access Code - 3972058 (Domestic) 312-470-0178 - Access Code - 3972058 (International) 800-3...
Back to Newsroom